Shots: Novimmune to receive $115.86M, out of $518.76M and has already received $402.9M under its exclusive license agreement signed with Sobi in 2018. Sobi to get IP & patent rights, […]readmore
Tags : emapalumab
Regulatory
Sobi’s Gamifant (emapalumab) Receives FDA Approval for Primary Haemophagocytic Lymphohistiocytosis
Shots: The approval is based on P-II/III (NCT01818492) study results assessing Gamifant IV in patients with primary HLH, evaluating its safety, efficacy and tolerability The P-II/III study resulted in meeting […]readmore